GUSTIN BLAD: Open Payments
NPI 1982979936 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 46 payments from 18 companies in 2025. Trend: 2023 $748 · 2024 $641 · 2025 $1,037
Food & beverage: $925Education: $112
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 5 | $176 |
| JAZZ PHARMACEUTICALS INC. | 3 | $126 |
| Pulmonx Corporation | 2 | $93 |
| GlaxoSmithKline, LLC. | 5 | $86 |
| HARMONY BIOSCIENCES LLC | 4 | $75 |
| Viatris Specialty LLC | 4 | $74 |
| Verona Pharma, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: UPTRAVI, XYWAV, CHARTIS CATHETER, NUCALA, WAKIX, YUPELRI, Ohtuvayre, WINREVAIR.
Industry payments across ID — which companies pay providers there.
